Covestor LTD Cogent Biosciences, Inc. Transaction History
Covestor LTD
- $170 Million
- Q2 2025
A detailed history of Covestor LTD transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Covestor LTD holds 18 shares of COGT stock, worth $207. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 11
63.64%
Holding current value
$207
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding COGT
# of Institutions
191Shares Held
117MCall Options Held
62KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$105 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$104 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$103 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$84.2 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$80.4 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $760M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...